The Decade of Non-Invasive Staging

added blog Wellness

2026-01-08 15:22:02 -

As pharmaceutical companies race to bring the first blockbuster NASH treatments to market, the need for reliable staging tools has never been greater. The current Non-Alcoholic Steatohepatitis Biomarkers Market forecast indicates a massive surge in demand for fibrosis markers through 2032. With the market expected to reach nearly USD 13.23 billion, the focus is shifting toward "point-of-care"...

0 Comments 0 Shares 24 Views 0 Reviews